BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 153 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,836 | -32.8% | 6,000 | +7.5% | 0.00% | – |
| Q2 2023 | $123,259 | +5.3% | 5,579 | +3.6% | 0.00% | – |
| Q1 2023 | $117,088 | +34.6% | 5,386 | +12.5% | 0.00% | – |
| Q4 2022 | $87,000 | -29.3% | 4,788 | -11.9% | 0.00% | – |
| Q3 2022 | $123,000 | +78.3% | 5,435 | +7.7% | 0.00% | – |
| Q2 2022 | $69,000 | -33.7% | 5,046 | +10.2% | 0.00% | – |
| Q1 2022 | $104,000 | -82.2% | 4,577 | -70.8% | 0.00% | -100.0% |
| Q4 2021 | $585,000 | -24.1% | 15,700 | -13.9% | 0.00% | -50.0% |
| Q3 2021 | $771,000 | +5.3% | 18,232 | +10.9% | 0.00% | 0.0% |
| Q2 2021 | $732,000 | +275.4% | 16,433 | +201.5% | 0.00% | – |
| Q1 2021 | $195,000 | -86.3% | 5,451 | -84.7% | 0.00% | -100.0% |
| Q4 2020 | $1,426,000 | +15744.4% | 35,741 | +11618.4% | 0.00% | – |
| Q3 2020 | $9,000 | -57.1% | 305 | -76.6% | 0.00% | – |
| Q2 2020 | $21,000 | +600.0% | 1,305 | +327.9% | 0.00% | – |
| Q1 2020 | $3,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |